Popular topics to explore
WATCH OUT FOR CORPORATE ACTIONS
Watch out for the Corporate actions today 29-May-2026 on the below mentioned stocks: - Life Insurance Corporation of India (LIC) : - Life Insurance Corporation of India 1:1 Bonus Issue (Investors receive 1 free additional share for every…
Earnings Alert: Stocks in Focus Ahead of Q4 Announcements
📊 Q4 Results Watch | Earnings Announcement Today
Investors and market participants will closely track Q4 earnings today from:
• GRASIM
• APOLLOHOSP
• LENSKART
• OLAELEC
• BOSCHLTD
• !Dr Agarwals Eye Hospital
• ERIS
• !HCL-…
Swing Bullish Strategy – Eagle Momentum (Weekly)
Swing Bullish Strategy – Eagle Momentum (Weekly)
BANDHANBNK has been outperformed Nifty 500 over last 1 week.
The Weekly Eagle Momentum strategy focuses on identifying stocks showing strong short-term relative strength compared to the…
Eris Lifesciences Receives HALMED Inspection Findings; Minimal Operational Impact Expected
Eris Lifesciences has received inspection findings from Croatia's HALMED agency following a March 9–13, 2026 audit of its two Ahmedabad manufacturing units: Unit 1 (general liquid/dry powder injectables) and Unit 2 (betalactam dry powder in…
Eris Lifesciences Ltd.
ERIS s is a chronic‑focused branded‑generics company in cardio‑metabolic and related therapies.
It operates with a pure‑India, high‑margin, specialty model.
Acquisitions in derma/endocrine expand its therapy coverage.
Risks are doctor‑…
Launch of Weekly Shot of Semaglutide - ERIS Lifesciences Ltd
Code BSE: 540596 NSE: ERIS
Eris Lifesciences Limited a leading Indian branded formulations company, today announced a breakthrough step in expanding access to advanced diabetes care with the launch of its generic Semaglutide under the…
2nd Mar · SEBI-Registered Analyst
Short Term Investing with M.J Research · 2nd Mar
High delivery stocks as on 02/03/26
Symbol Delivered Qty
ABLBL 6378940
CHALET 385894
BIRLACORPN 194203
KEI 663980
PTCIL 19249
INDIGO 1593968
NIVABUPA 922288
ERIS 119987
RELAXO 102236
TEJASNET 7599008
CAMS 1446779
VENTIVE 146595
CHALET
Natco Pharma & Eris Lifesciences Jump on Semaglutide Deal News
NATCOPHARM Shares of Natco Pharma and Eris Lifesciences climbed strongly after both companies announced a partnership to commercialise the generic version of the diabetes and weight-management drug semaglutide in India, reflecting rising i…
Eris Lifesciences Shares Gain After Semaglutide Partnership News
ERIS Eris Lifesciences saw its stock rise on the National Stock Exchange as the company announced a strategic partnership with Natco Pharma to launch generic semaglutide in India, a drug widely used for managing type-2 diabetes and weight…
Update for investors of ERIS
ERIS is currently trading at Rs. 1382.95, up by 31.60 points or 2.34% from its previous closing of Rs. 1351.35 on the BSE.
The scrip opened at Rs. 1350.00 and has touched a high and low of Rs. 1402.00 and Rs. 1350.00 respectively. So far…
ERIS
On January 16, 2026, the Executive Committee of Eris Lifesciences Limited approved the allotment of 23,06,372 equity shares with a face value of Re. 1 each at an issue price of INR 1835.35 per share on a preferential basis to Mr. Naishadh S…
30th Dec · SEBI-Registered Analyst
Short Term Investing with M.J Research · 30th Dec
High delivery stocks as on 31/12/25
Symbol Delivered Qty GODREJIND 220058 ASIANPAINT 3737173 RKFORGE 2018072 TVSHLTD 29296 INDIANB 5756528 GLAXO 367035 BERGEPAINT 1596455 COROMANDEL 1171265 SOLARINDS 559188 EICHERMOT 1365824 HDFCLIFE 10551015 GODFRYPHLP 389713 MFSL 2338151 LT…
9th Dec · SEBI-Registered Analyst
Short Term Investing with M.J Research · 9th Dec
Stocks having high delivery quantity as on 09/12/25
Symbol Delivered Qty ANANDRATHI 2145048 ERIS 368418 GRINFRA 67960 TTML 8860476 JSWENERGY 17703640 BALRAMCHIN 801958 360ONE 1345198 HONASA 1958377 TTKPRESTIG 49978 PATANJALI 5307068 SOBHA 360559 CELLO 273611 RELINFRA 3804840 BRIGADE 743328 M…
ERIS Breaks 10-Day Losing Streak with Sharp Intraday Rally
As on 9 Dec 2025, ERIS ended a prolonged phase of selling pressure by snapping its 10-day consecutive negative closing streak. The stock witnessed strong buying interest during the session, rallying as much as 13.2% on an intraday basis b…
Eris Lifesciences – Flag Formation With Volume Breakout Above 30W SMA
ERIS
1. Clear Flag Pattern in Formation
Eris Lifesciences is currently forming a classic bullish flag pattern, a continuation structure often seen mid-trend.
Strong pole (sharp rally)
Sideways–downward consolidation inside a channel
P…
Stocks to Watch
Positive Bias
PETRONET , ONGC – Signed a 15-year binding term sheet for ethane unloading, storage and handling—strengthens gas value-chain infrastructure.
JSWSTEEL – Brokerages turn incrementally bullish after progress on BSPL monetiz…
Eris Opens Strong on Subsidiary Stake Buyout Plan, Ends Weak
As on 25 Nov 2025, ERIS opened on a positive note after announcing plans to acquire the remaining 30% stake in Swiss Parenterals for ₹423.3 crore, with consideration issued via 23.06 lakh preferential shares. The stock traded at its highe…
Eris Lifesciences to fully own Swiss Parenterals
ERIS is set to acquire the remaining 30% stake in its injectables subsidiary Swiss Parenterals for Rs 423 crore, moving from 70% to 100% ownership to consolidate control, simplify decision-making, and integrate export-led sterile capabilit…
80 stocks : Excellent Results 🔥🔥 - Market is rewarding great results - Only selected stocks with good results are firing 🔥 ✅ Save It 1. Pondy Oxides 2. Vintage Coffee 3. Denta Water 4. CCL Products 5. Interarch 6. Epacck Prefab 7. MCX…
ERIS
As of 13 November 2025, the technical trend has changed from mildly bullish to sideways. The current technical stance is neutral, with mixed signals across various indicators. The weekly MACD is mildly bearish, while the monthly MACD remain…
